Pain Patches Market
This report covers the pain patches market through analysis of market size, revenue forecast, competitive landscape, demand outlook, growth drivers, restraints, product type trends, therapeutic application developments, and strategic growth opportunities.
Pain Patches Market Size, Market Forecast and Outlook By FMI
The pain patches market was valued at USD 3.10 billion in 2025, projected to reach USD 3.36 billion in 2026, and is forecast to expand to USD 7.53 billion by 2036 at a 8.40% CAGR. Structural shifts in end-use procurement cycles and tightening performance specifications across downstream sectors are accelerating capital allocation toward pain patches categories. Procurement teams operating across global supply chains now require standardized compliance certifications, compressing qualification timelines and elevating minimum specification thresholds for approved supplier lists.
Capital expenditure planning cycles across verticals consuming pain patches products have shifted from discretionary upgrades to mandated replacements. Regulatory frameworks governing material performance, safety testing, and environmental compliance are tightening across all major consumption regions. Buyers evaluating supplier contracts increasingly weight lifecycle cost models over upfront unit pricing, favoring suppliers with vertically integrated operations and certified testing capabilities.
Summary of Pain Patches Market
- The market is estimated at USD 3.10 billion in 2025.
- The market is projected to reach USD 7.53 billion by 2036.
- The market is expected to grow at a CAGR of 8.40% from 2026 to 2036.
- The forecast period represents an incremental opportunity of USD 4.17 billion.
- Opioid patches lead by product type with a 38.7% share in 2026.
- Pain relief dominates by therapeutic application with a 62.4% share in 2026.
- The market is driven by rising compliance requirements and adoption of higher-specification products.
- Product scope includes opioid and non-opioid patches such as buprenorphine and fentanyl-based formulations.
- China (10.80%), India (10.00%), and Germany (9.20%) are among the fastest-growing markets.
- Key companies in the market include Johnson & Johnson Services, Inc., Viatris, Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Hisamitsu Pharmaceutical Co., Inc., GlaxoSmithKline Plc., and Novartis AG.
Pain Patches Market Key Takeaways
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 3.36 billion |
| Industry Value (2036) | USD 7.53 billion |
| CAGR (2026-2036) | 8.40% |
Source: Future Market Insights, 2026
Regional deployment parameters reflect differentiated adoption velocities. China sets the pace with a 10.80% CAGR, followed by India at 10.00% as infrastructure expansion programs bypass legacy procurement constraints. Germany operations advance at a 9.20% rate, supported by regulatory compliance mandates. Brazil tracks at 8.40%. USA networks maintain a 7.60% expansion trajectory. UK registers a 6.80% pace. Japan expands at a 6.00% trajectory.
Pain Patches Market Definition
Pain Patches constitutes the material, product, or technology category defined by its primary industrial function within downstream manufacturing and end-use sectors. The scope encompasses standardized and specialty configurations compliant with global performance and safety specifications. Core inclusions govern products meeting defined procurement parameters across industrial, commercial, and institutional buyer categories.
Pain Patches Market Inclusions
Market scope includes Opioid Patches, Buprenorphine, Fentanyl, Non-opioid Patches, Diclofenac patches configurations and related product variants. Global and regional market sizes, forecast period 2026 to 2036, and segment breakdowns by product type, therapeutic application, distribution channel are fully incorporated within the analytical boundary.
Pain Patches Market Exclusions
Standard commodity alternatives lacking specialized performance certifications are excluded. Downstream finished goods, standalone accessory components, and non-standardized custom fabrications fall outside the analytical parameters. Legacy product formats without current industry specification compliance are explicitly omitted from the valuation.
Pain Patches Market Research Methodology
- Primary Research: Analysts engaged with procurement specification leads, technical managers, and supply chain directors across key consumption sectors to map decision gates triggering product upgrades and supplier requalification.
- Desk Research: Data collection phases aggregated regulatory compliance frameworks, industry standards ratification schedules, and published procurement guidelines from major institutional buyers.
- Market-Sizing and Forecasting: Baseline values derive from a bottom-up aggregation of product volumes and contract values, applying region-specific adoption curves to project future demand velocity.
- Data Validation and Update Cycle: Projections are tested against publicly reported expenditure guidance from leading industrial consumers and trade association production statistics.
What is Driving Demand for Pain Patches?
Pain patch is a medicated adhesive patch that is used to relieve the pain by placing it on the skin. Pain patch uses a transdermal route and therefore provides an advantage of controlled delivery of medication as compared to other routes of administration. This advantage may result in increasing the sales of pain patches during the forecast period.
Increasing number of accidents that result in severe injury is expected to drive the growth of pain patches market across the globe. According to the Association for Safe International Travel, in 2021, approximately 4.4. million individuals were severely injured to require medical attention in the USA Moreover, increasing number of sports related injuries will also lead to a rise in demand for pain patch market.
In addition, changes in lifestyle and emergence of more office related jobs that needs continuous sitting in one position for too long may result in back related ailments among others. This will also lead to significant growth in the pain patches market.
Increasing Prevalence of Arthritis Expected to Augment the Growth of Pain Patches Market
Increasing chronic and acute pain-related diseases is expected to reflect positive growth for pain patches market. One such disease is arthritis which results in severe joint pain. The increasing prevalence of arthritis mainly is expected to increase the demand for pain patches. According to CDC, in 2018, an estimated 22.7% of the USA population of adults had doctor-diagnosed arthritis.
USA and Canada Pain Patches Market Outlook
.webp "Top Country Growth Comparison Pain Patches Market Cagr (2026 2036)")
USA and Canada are among the largest market for pain patches market making North America a dominant player. The adoption of transdermal pain patches has increased in North America for pain management of certain conditions, which includes cancer. Pain patches are quite effective as compared to painkillers as they deliver pain management drugs at a predetermined rate across the dermis and achieve a local or systemic effect.
This indicates that the high prevalence of cancer will lead to a rise in demand for the pain patches market. According to National Cancer Institute, in 2018 an estimated 16,353,421 people living with cancer of any site in the USA
Europe Demand Outlook for Pain Patches
Increasing usage of pain patches for pain management for non-cancer conditions is expected to drive the growth of the pain patches market in this regions. Additionally, the increasing research and development funding and increasing focus of the European governments on the healthcare system also represents steady growth for pain patches market.
Moreover, favourable reimbursement policies in many European countries will also boost further growth of the pain patches market.
Who are the Key Manufacturers and Suppliers of Pain Patches?
Some of the leading manufacturers operating in the pain patches market include
- Viatris, Inc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Hisamitsu Pharmaceutical Co., Inc.
- GlaxoSmithKline Plc.
- Novartis AG
- Nichiban Co., Ltd.
- Teikoku Seiyaku Co, Ltd.
- Mentholatum Company.
Many leading manufacturers in the pain patches market are focusing on getting FDA approvals for their products. For instance, in July 2021, the FDA approved an 8% capsaicin pain patch for diabetic neuropathy. Manufacturers in the market are also focused carrying out acquisitions that will broaden their product portfolio.
In July 2019, GlaxoSmithKline acquired the Pfizer’s Consumer Health Business which includes OTC products for topical pain management.
The Report Covers Exhaustive Analysis on
- Market Segments
- Market Dynamics
- Historical Actual Market Size, 2016 - 2021
- Market Size & Forecast 2021 to 2031
- Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Market Drivers and Restraints
Scope of the Report
| Metric | Value |
|---|---|
| Quantitative Units | USD 3.36 billion to USD 7.53 billion, at a CAGR of 8.40% |
| Market Definition | Pain Patches encompasses the material, product, or technology category serving downstream industrial, commercial, and institutional end-use sectors under defined performance and safety specifications. |
| Product Type Segmentation | Opioid Patches, Buprenorphine, Fentanyl, Non-opioid Patches, Diclofenac patches, Lidocaine patches, Ketoprofen patches, Capsaicin patches, Methyl Salicylate Patches |
| Therapeutic Application Segmentation | Pain relief, Cough Suppression, Anesthesia, Diarrhea Suppression, Smoking Cessation |
| Distribution Channel Segmentation | Retail Pharmacies, Hospital Pharmacies, Online pharmacies |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa |
| Countries Covered | China, India, Germany, Brazil, USA, UK, Japan, and 40 plus countries |
| Key Companies Profiled | Johnson & Johnson Services, Inc., Viatris, Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Hisamitsu Pharmaceutical Co., Inc., GlaxoSmithKline Plc., Novartis AG, Nichiban Co., Ltd., Teikoku Seiyaku Co, Ltd., Mentholatum Company |
| Forecast Period | 2026 to 2036 |
| Approach | Forecasting models apply a bottom-up methodology starting with global installed base metrics and projecting conversion rates to higher-specification product categories. |
Key Segments of Pain Patches Market
By Product Type:
- Opioid Patches
- Buprenorphine
- Fentanyl
- Non-opioid Patches
- Diclofenac patches
- Lidocaine patches
- Ketoprofen patches
- Capsaicin patches
- Methyl Salicylate Patches
By Therapeutic Application:
- Pain relief
- Cough Suppression
- Anesthesia
- Diarrhea Suppression
- Smoking Cessation
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Bibliography
- 1. Organisation for Economic Co-operation and Development. (2025, June). Industrial performance and competitiveness indicators. OECD.
- 2. World Bank Group. (2025). Global economic prospects: Industrial supply chains and trade facilitation. World Bank.
- 3. United Nations Industrial Development Organization. (2025). Industrial development report: Manufacturing and global value chains. UNIDO.
- 4. International Organization for Standardization. (2025). ISO standards catalogue: Materials testing and quality management. ISO.
- 5. European Commission, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs. (2025). Single market for goods: Industrial product compliance. European Commission.
- 6. USA Bureau of Labor Statistics. (2025). Producer price indexes for intermediate demand. USA Department of Labor.
This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with primary research documentation.
Frequently Asked Questions
How large is the demand for Pain Patches in the global market in 2026?
Demand for Pain Patches in the global market is estimated to be valued at USD 3.36 billion in 2026.
What will be the market size of Pain Patches in the global market by 2036?
Market size for Pain Patches is projected to reach USD 7.53 billion by 2036.
What is the expected demand growth for Pain Patches in the global market between 2026 and 2036?
Demand for Pain Patches is expected to grow at a CAGR of 8.40% between 2026 and 2036.
Which Product Type is poised to lead global sales by 2026?
Opioid Patches accounts for 38.7% in 2026, driven by established procurement specifications and downstream integration requirements.
What is driving demand in China?
China leads with a 10.80% CAGR as greenfield industrial facilities deploying modern procurement frameworks create scaled demand for specification-compliant pain patches products.
What is the India growth outlook in this report?
India is projected to grow at a CAGR of 10.00% during 2026 to 2036.
What is Pain Patches and what is it mainly used for?
Pain Patches constitutes the specialized material, product, or technology category designed for defined industrial, commercial, and institutional applications. End-use sectors primarily deploy it to meet performance, safety, and regulatory compliance requirements.
How does FMI build and validate the Pain Patches forecast?
Forecasting models apply a bottom-up methodology starting with global installed base metrics and cross-validate projections against quarterly industry production and trade volumes.
Table of Content
- Executive Summary
- Global Market Outlook
- Demand to side Trends
- Supply to side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Research Methodology
- Chapter Orientation
- Analytical Lens and Working Hypotheses
- Market Structure, Signals, and Trend Drivers
- Benchmarking and Cross-market Comparability
- Market Sizing, Forecasting, and Opportunity Mapping
- Research Design and Evidence Framework
- Desk Research Programme (Secondary Evidence)
- Company Annual and Sustainability Reports
- Peer-reviewed Journals and Academic Literature
- Corporate Websites, Product Literature, and Technical Notes
- Earnings Decks and Investor Briefings
- Statutory Filings and Regulatory Disclosures
- Technical White Papers and Standards Notes
- Trade Journals, Industry Magazines, and Analyst Briefs
- Conference Proceedings, Webinars, and Seminar Materials
- Government Statistics Portals and Public Data Releases
- Press Releases and Reputable Media Coverage
- Specialist Newsletters and Curated Briefings
- Sector Databases and Reference Repositories
- FMI Internal Proprietary Databases and Historical Market Datasets
- Subscription Datasets and Paid Sources
- Social Channels, Communities, and Digital Listening Inputs
- Additional Desk Sources
- Expert Input and Fieldwork (Primary Evidence)
- Primary Modes
- Qualitative Interviews and Expert Elicitation
- Quantitative Surveys and Structured Data Capture
- Blended Approach
- Why Primary Evidence is Used
- Field Techniques
- Interviews
- Surveys
- Focus Groups
- Observational and In-context Research
- Social and Community Interactions
- Stakeholder Universe Engaged
- C-suite Leaders
- Board Members
- Presidents and Vice Presidents
- R&D and Innovation Heads
- Technical Specialists
- Domain Subject-matter Experts
- Scientists
- Physicians and Other Healthcare Professionals
- Governance, Ethics, and Data Stewardship
- Research Ethics
- Data Integrity and Handling
- Primary Modes
- Tooling, Models, and Reference Databases
- Desk Research Programme (Secondary Evidence)
- Data Engineering and Model Build
- Data Acquisition and Ingestion
- Cleaning, Normalisation, and Verification
- Synthesis, Triangulation, and Analysis
- Quality Assurance and Audit Trail
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- Global Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
- Historical Market Size Value (USD Million) Analysis, 2021 to 2025
- Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
- Y to o to Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Product Type
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Product Type , 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Product Type , 2026 to 2036
- Opioid Patches
- Buprenorphine
- Fentanyl
- Non-opioid Patches
- Diclofenac patches
- Lidocaine patches
- Ketoprofen patches
- Capsaicin patches
- Methyl Salicylate Patches
- Opioid Patches
- Y to o to Y Growth Trend Analysis By Product Type , 2021 to 2025
- Absolute $ Opportunity Analysis By Product Type , 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Therapeutic Application
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Therapeutic Application, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Therapeutic Application, 2026 to 2036
- Pain relief
- Cough Suppression
- Anesthesia
- Diarrhea Suppression
- Smoking Cessation
- Pain relief
- Y to o to Y Growth Trend Analysis By Therapeutic Application, 2021 to 2025
- Absolute $ Opportunity Analysis By Therapeutic Application, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Distribution Channel
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Distribution Channel, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Distribution Channel, 2026 to 2036
- Retail Pharmacies
- Hospital Pharmacies
- Online pharmacies
- Retail Pharmacies
- Y to o to Y Growth Trend Analysis By Distribution Channel, 2021 to 2025
- Absolute $ Opportunity Analysis By Distribution Channel, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East & Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- USA
- Canada
- Mexico
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Key Takeaways
- Latin America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Brazil
- Chile
- Rest of Latin America
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Key Takeaways
- Western Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Key Takeaways
- Eastern Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Key Takeaways
- East Asia Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- China
- Japan
- South Korea
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Key Takeaways
- South Asia and Pacific Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Key Takeaways
- Middle East & Africa Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Key Takeaways
- Key Countries Market Analysis
- USA
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Canada
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Mexico
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Brazil
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Chile
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Germany
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- UK
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Italy
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Spain
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- France
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- India
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- ASEAN
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Australia & New Zealand
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- China
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Japan
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- South Korea
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Russia
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Poland
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Hungary
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Kingdom of Saudi Arabia
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Turkiye
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- South Africa
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- USA
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Product Type
- By Therapeutic Application
- By Distribution Channel
- Competition Analysis
- Competition Deep Dive
- Johnson & Johnson Services, Inc.
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Viatris, Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Hisamitsu Pharmaceutical Co., Inc.
- GlaxoSmithKline Plc.
- Novartis AG
- Nichiban Co., Ltd.
- Teikoku Seiyaku Co, Ltd.
- Mentholatum Company
- Johnson & Johnson Services, Inc.
- Competition Deep Dive
- Assumptions & Acronyms Used
List of Tables
- Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
- Table 2: Global Market Value (USD Million) Forecast by Product Type , 2021 to 2036
- Table 3: Global Market Value (USD Million) Forecast by Therapeutic Application, 2021 to 2036
- Table 4: Global Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
- Table 5: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 6: North America Market Value (USD Million) Forecast by Product Type , 2021 to 2036
- Table 7: North America Market Value (USD Million) Forecast by Therapeutic Application, 2021 to 2036
- Table 8: North America Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
- Table 9: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 10: Latin America Market Value (USD Million) Forecast by Product Type , 2021 to 2036
- Table 11: Latin America Market Value (USD Million) Forecast by Therapeutic Application, 2021 to 2036
- Table 12: Latin America Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
- Table 13: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 14: Western Europe Market Value (USD Million) Forecast by Product Type , 2021 to 2036
- Table 15: Western Europe Market Value (USD Million) Forecast by Therapeutic Application, 2021 to 2036
- Table 16: Western Europe Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
- Table 17: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 18: Eastern Europe Market Value (USD Million) Forecast by Product Type , 2021 to 2036
- Table 19: Eastern Europe Market Value (USD Million) Forecast by Therapeutic Application, 2021 to 2036
- Table 20: Eastern Europe Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
- Table 21: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 22: East Asia Market Value (USD Million) Forecast by Product Type , 2021 to 2036
- Table 23: East Asia Market Value (USD Million) Forecast by Therapeutic Application, 2021 to 2036
- Table 24: East Asia Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
- Table 25: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 26: South Asia and Pacific Market Value (USD Million) Forecast by Product Type , 2021 to 2036
- Table 27: South Asia and Pacific Market Value (USD Million) Forecast by Therapeutic Application, 2021 to 2036
- Table 28: South Asia and Pacific Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
- Table 29: Middle East & Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 30: Middle East & Africa Market Value (USD Million) Forecast by Product Type , 2021 to 2036
- Table 31: Middle East & Africa Market Value (USD Million) Forecast by Therapeutic Application, 2021 to 2036
- Table 32: Middle East & Africa Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
List of Figures
- Figure 1: Global Market Pricing Analysis
- Figure 2: Global Market Value (USD Million) Forecast 2021-2036
- Figure 3: Global Market Value Share and BPS Analysis by Product Type , 2026 and 2036
- Figure 4: Global Market Y-o-Y Growth Comparison by Product Type , 2026-2036
- Figure 5: Global Market Attractiveness Analysis by Product Type
- Figure 6: Global Market Value Share and BPS Analysis by Therapeutic Application, 2026 and 2036
- Figure 7: Global Market Y-o-Y Growth Comparison by Therapeutic Application, 2026-2036
- Figure 8: Global Market Attractiveness Analysis by Therapeutic Application
- Figure 9: Global Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
- Figure 10: Global Market Y-o-Y Growth Comparison by Distribution Channel, 2026-2036
- Figure 11: Global Market Attractiveness Analysis by Distribution Channel
- Figure 12: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
- Figure 13: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
- Figure 14: Global Market Attractiveness Analysis by Region
- Figure 15: North America Market Incremental Dollar Opportunity, 2026-2036
- Figure 16: Latin America Market Incremental Dollar Opportunity, 2026-2036
- Figure 17: Western Europe Market Incremental Dollar Opportunity, 2026-2036
- Figure 18: Eastern Europe Market Incremental Dollar Opportunity, 2026-2036
- Figure 19: East Asia Market Incremental Dollar Opportunity, 2026-2036
- Figure 20: South Asia and Pacific Market Incremental Dollar Opportunity, 2026-2036
- Figure 21: Middle East & Africa Market Incremental Dollar Opportunity, 2026-2036
- Figure 22: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 23: North America Market Value Share and BPS Analysis by Product Type , 2026 and 2036
- Figure 24: North America Market Y-o-Y Growth Comparison by Product Type , 2026-2036
- Figure 25: North America Market Attractiveness Analysis by Product Type
- Figure 26: North America Market Value Share and BPS Analysis by Therapeutic Application, 2026 and 2036
- Figure 27: North America Market Y-o-Y Growth Comparison by Therapeutic Application, 2026-2036
- Figure 28: North America Market Attractiveness Analysis by Therapeutic Application
- Figure 29: North America Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
- Figure 30: North America Market Y-o-Y Growth Comparison by Distribution Channel, 2026-2036
- Figure 31: North America Market Attractiveness Analysis by Distribution Channel
- Figure 32: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 33: Latin America Market Value Share and BPS Analysis by Product Type , 2026 and 2036
- Figure 34: Latin America Market Y-o-Y Growth Comparison by Product Type , 2026-2036
- Figure 35: Latin America Market Attractiveness Analysis by Product Type
- Figure 36: Latin America Market Value Share and BPS Analysis by Therapeutic Application, 2026 and 2036
- Figure 37: Latin America Market Y-o-Y Growth Comparison by Therapeutic Application, 2026-2036
- Figure 38: Latin America Market Attractiveness Analysis by Therapeutic Application
- Figure 39: Latin America Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
- Figure 40: Latin America Market Y-o-Y Growth Comparison by Distribution Channel, 2026-2036
- Figure 41: Latin America Market Attractiveness Analysis by Distribution Channel
- Figure 42: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 43: Western Europe Market Value Share and BPS Analysis by Product Type , 2026 and 2036
- Figure 44: Western Europe Market Y-o-Y Growth Comparison by Product Type , 2026-2036
- Figure 45: Western Europe Market Attractiveness Analysis by Product Type
- Figure 46: Western Europe Market Value Share and BPS Analysis by Therapeutic Application, 2026 and 2036
- Figure 47: Western Europe Market Y-o-Y Growth Comparison by Therapeutic Application, 2026-2036
- Figure 48: Western Europe Market Attractiveness Analysis by Therapeutic Application
- Figure 49: Western Europe Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
- Figure 50: Western Europe Market Y-o-Y Growth Comparison by Distribution Channel, 2026-2036
- Figure 51: Western Europe Market Attractiveness Analysis by Distribution Channel
- Figure 52: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 53: Eastern Europe Market Value Share and BPS Analysis by Product Type , 2026 and 2036
- Figure 54: Eastern Europe Market Y-o-Y Growth Comparison by Product Type , 2026-2036
- Figure 55: Eastern Europe Market Attractiveness Analysis by Product Type
- Figure 56: Eastern Europe Market Value Share and BPS Analysis by Therapeutic Application, 2026 and 2036
- Figure 57: Eastern Europe Market Y-o-Y Growth Comparison by Therapeutic Application, 2026-2036
- Figure 58: Eastern Europe Market Attractiveness Analysis by Therapeutic Application
- Figure 59: Eastern Europe Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
- Figure 60: Eastern Europe Market Y-o-Y Growth Comparison by Distribution Channel, 2026-2036
- Figure 61: Eastern Europe Market Attractiveness Analysis by Distribution Channel
- Figure 62: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 63: East Asia Market Value Share and BPS Analysis by Product Type , 2026 and 2036
- Figure 64: East Asia Market Y-o-Y Growth Comparison by Product Type , 2026-2036
- Figure 65: East Asia Market Attractiveness Analysis by Product Type
- Figure 66: East Asia Market Value Share and BPS Analysis by Therapeutic Application, 2026 and 2036
- Figure 67: East Asia Market Y-o-Y Growth Comparison by Therapeutic Application, 2026-2036
- Figure 68: East Asia Market Attractiveness Analysis by Therapeutic Application
- Figure 69: East Asia Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
- Figure 70: East Asia Market Y-o-Y Growth Comparison by Distribution Channel, 2026-2036
- Figure 71: East Asia Market Attractiveness Analysis by Distribution Channel
- Figure 72: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 73: South Asia and Pacific Market Value Share and BPS Analysis by Product Type , 2026 and 2036
- Figure 74: South Asia and Pacific Market Y-o-Y Growth Comparison by Product Type , 2026-2036
- Figure 75: South Asia and Pacific Market Attractiveness Analysis by Product Type
- Figure 76: South Asia and Pacific Market Value Share and BPS Analysis by Therapeutic Application, 2026 and 2036
- Figure 77: South Asia and Pacific Market Y-o-Y Growth Comparison by Therapeutic Application, 2026-2036
- Figure 78: South Asia and Pacific Market Attractiveness Analysis by Therapeutic Application
- Figure 79: South Asia and Pacific Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
- Figure 80: South Asia and Pacific Market Y-o-Y Growth Comparison by Distribution Channel, 2026-2036
- Figure 81: South Asia and Pacific Market Attractiveness Analysis by Distribution Channel
- Figure 82: Middle East & Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 83: Middle East & Africa Market Value Share and BPS Analysis by Product Type , 2026 and 2036
- Figure 84: Middle East & Africa Market Y-o-Y Growth Comparison by Product Type , 2026-2036
- Figure 85: Middle East & Africa Market Attractiveness Analysis by Product Type
- Figure 86: Middle East & Africa Market Value Share and BPS Analysis by Therapeutic Application, 2026 and 2036
- Figure 87: Middle East & Africa Market Y-o-Y Growth Comparison by Therapeutic Application, 2026-2036
- Figure 88: Middle East & Africa Market Attractiveness Analysis by Therapeutic Application
- Figure 89: Middle East & Africa Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
- Figure 90: Middle East & Africa Market Y-o-Y Growth Comparison by Distribution Channel, 2026-2036
- Figure 91: Middle East & Africa Market Attractiveness Analysis by Distribution Channel
- Figure 92: Global Market - Tier Structure Analysis
- Figure 93: Global Market - Company Share Analysis
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
